Insight Molecular Diagnostics Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a IMDX research report →
About the company
OncoCyte Corporation functions as a molecular diagnostics firm specializing in the research, development, and market introduction of distinctive, laboratory-developed tests aimed at cancer identification. Its operations span both the United States and international territories. The company's key offerings include DetermaRx, a molecular diagnostic tool tailored for detecting early-stage adenocarcinoma of the lung, and DetermaIO, a proprietary gene expression analysis.
- CEO
- Joshua Riggs
- IPO
- 2015
- Employees
- 46
- HQ
- Nashville, TN, US
Price Chart
- Market Cap
- $154.07M
- P/E
- -3.79
- P/S
- 79.05
- P/B
- -18.53
- EV/EBITDA
- -2.84
- Div Yield
- 0.00%
- Gross Margin
- 19.47%
- Op Margin
- -2112.42%
- Net Margin
- -2454.64%
- ROE
- 380.80%
- ROIC
- -136.40%
- Revenue
- $4.05M · 115.58%
- Net Income
- $-50,222,000 · 17.21%
- EPS
- $-1.65 · 64.60%
- Op Income
- $-30,578,000
- FCF YoY
- -19.50%
- 52W High
- $8.51
- 52W Low
- $2.33
- 50D MA
- $5.39
- 200D MA
- $5.34
- Beta
- 1.76
- Avg Volume
- 363.19K
Get TickerSpark's AI analysis on IMDX
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Jun 11, 26 | SILVERMAN LOU | other | 26,943 |
| Jun 11, 26 | Last Andrew J. | other | 26,943 |
| Jun 11, 26 | Arno Andrew | other | 32,331 |
| Apr 27, 26 | BROADWOOD PARTNERS, L.P. | buy | 0 |
| Apr 27, 26 | BROADWOOD PARTNERS, L.P. | buy | 250,923 |
| Apr 24, 26 | BROADWOOD PARTNERS, L.P. | buy | 38,880 |
| Apr 24, 26 | BROADWOOD PARTNERS, L.P. | buy | 0 |
| Apr 23, 26 | BROADWOOD PARTNERS, L.P. | buy | 0 |
| Apr 23, 26 | BROADWOOD PARTNERS, L.P. | buy | 280,381 |
| Apr 20, 26 | BROADWOOD PARTNERS, L.P. | buy | 0 |
Our IMDX coverage
Recent articles, reports, and earnings notes.
No research on IMDX yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate IMDX report →Similar companies
Peers in the same neighborhood.